Page 53 - IJB-10-5
P. 53

International Journal of Bioprinting                              Bioprinted tumor immune microenvironment




            71.  Almeida CR, Serra T, Oliveira MI, et al. Impact of 3-D   82.  Langhans SA. Three-dimensional in vitro cell culture models
               printed PLA-and chitosan-based scaffolds on human   in drug discovery and drug repositioning. Front Pharmacol.
               monocyte/macrophage responses: unraveling the effect of   2018;9:6.
               3-D structures on inflammation. Acta Biomater. 2014;10(2):      doi: 10.3389/fphar.2018.00006
               613-622.
               doi: 10.1016/j.actbio.2013.10.035               83.  Jenkins RW, Barbie DA, Flaherty KT. Mechanisms of
                                                                  resistance to immune checkpoint inhibitors.  Br J Cancer.
            72.  Kasravi M, Ahmadi A, Babajani A, et al. Immunogenicity of   2018;118(1):9-16.
               decellularized extracellular matrix scaffolds: a bottleneck in      doi: 10.1038/bjc.2017.434
               tissue engineering and regenerative medicine. Biomater Res.
               2023;27(1):10.                                  84.  Cattaneo CM, Dijkstra KK, Fanchi LF, et al. Tumor
               doi: 10.1186/s40824-023-00348-z                    organoid-T-cell coculture systems. Nat Protoc. 2020;15(1):
                                                                  15-39.
            73.  Yue K, Trujillo-de Santiago G, Alvarez MM, et al.      doi: 10.1038/s41596-019-0232-9
               Synthesis, properties, and biomedical applications of
               gelatin methacryloyl (GelMA) hydrogels.  Biomaterials.   85.  Jin Z, Li X, Zhang X, et al. Engineering the fate and function
               2015;73:254-271.                                   of human T-Cells via 3D bioprinting.  Biofabrication.
               doi: 10.1016/j.biomaterials.2015.08.045            2021;13(3):035016.
                                                                  doi: 10.1088/1758-5090/abd56b
            74.  Donaldson AR, Tanase CE, Awuah D, et al. Photocrosslinkable
               gelatin hydrogels modulate the production of the major pro-  86.  Kim D, Jo S, Lee D, et al. NK cells encapsulated in micro/
               inflammatory cytokine, TNF-α, by human mononuclear   macropore-forming hydrogels via 3D bioprinting for tumor
               cells. Front Bioeng Biotechnol. 2018;6:116.        immunotherapy. Biomater Res. 2023;27(1):60.
               doi: 10.3389/fbioe.2018.00116                      doi:  10.1186/s40824-023-00403-9
            75.  Chakraborty J, Roy S, Ghosh S. Regulation of decellularized   87.  Xu Y, Zhu W, Wu J, et al. 3D‐printed dendritic cell vaccines
               matrix mediated immune response.  Biomater  Sci.   for post‐surgery cancer immunotherapy. Adv Funct Mater.
               2020;8(5):1194-1215.                               2024;34(33):2400507.
               doi:  10.1039/c9bm01780a                           doi: 10.1002/adfm.202400507
            76.  Heinrich MA, Bansal R, Lammers T, et al. 3D‐bioprinted mini‐  88.  Li C, Jin B, Sun H, et al. Exploring the function of stromal
               brain: a glioblastoma model to study cellular interactions   cells in cholangiocarcinoma by three-dimensional
               and therapeutics. Adv Mater. 2019;31(14):1806590.  bioprinting immune microenvironment model.  Front
               doi: 10.1002/adma.201806590                        Immunol. 2022;13:941289.
                                                                  doi: 10.3389/fimmu.2022.941289
            77.  Reynolds DS, de Lázaro I, Blache ML, et al. Microporogen-
               structured  collagen  matrices  for  embedded  bioprinting   89.  Grolman JM, Zhang D, Smith AM, et al. Rapid 3D extrusion
               of tumor models for immuno-oncology.  Adv Mater.   of synthetic tumor microenvironments.  Adv Mater.
               2023;35(33):e2210748.                              2015;27(37):5512.
               doi: 10.1002/adma.202210748                        doi: 10.1002/adma.201501729
            78.  Morley CD, Flores CT, Drake JA, et al. Spatiotemporal T   90.  Gong Z, Huang L, Tang X, et al. Acoustic droplet printing
               cell dynamics in a 3D bioprinted immunotherapy model.   tumor organoids for modeling bladder tumor immune
               Bioprinting. 2022;28:e00231.                       microenvironment within a week.  Adv Healthc Mater.
               doi: 10.1016/j.bprint.2022.e00231                  2021;10(22):2101312.
                                                                  doi: 10.1002/adhm.202101312
            79.  Mazzaglia C, Sheng Y, Rodrigues LN, et al. Deployable
               extrusion bioprinting of compartmental tumoroids with   91.  Xu Y, Saiding Q, Zhou X, et al. Electrospun fiber‐based
               cancer associated fibroblasts for immune cell interactions.   immune engineering in regenerative medicine. Smart Med.
               Biofabrication. 2023;15(2):025005.                 2024;3(1):e20230034.
               doi:  10.1088/1758-5090/acb1db                     doi: 10.1002/SMMD.20230034
            80.  Flores-Torres S, Dimitriou NM, Pardo LA, et al. Bioprinted   92.  Tang  M,  Xie  Q,  Gimple  RC,  et  al. Three-dimensional
               multicomponent hydrogel co-culture tumor-immune model   bioprinted  glioblastoma  microenvironments  model
               for assessing and simulating tumor-infiltrated lymphocyte   cellular dependencies and immune interactions.  Cell Res.
               migration and functional activation.  ACS Appl Mater   2020;30(10):833-853.
               Interfaces. 2023;15(28):33250-33262.               doi: 10.1038/s41422-020-0338-1
               doi: 10.1021/acsami.3c02995                     93.  Dey M, Kim MH, Nagamine M, et al. Biofabrication of 3D
            81.  Datta P, Dey M, Ataie Z, et al. 3D bioprinting for   breast cancer models for dissecting the cytotoxic response of
               reconstituting the cancer microenvironment.  NPJ  Precis   human T cells expressing engineered MAIT cell receptors.
               Oncol. 2020;4(1):18.                               Biofabrication. 2022;14(4):044105.
               doi: 10.1038/s41698-020-0121-2                     doi: 10.1088/1758-5090/ac925a

            Volume 10 Issue 5 (2024)                        45                                doi: 10.36922/ijb.3988
   48   49   50   51   52   53   54   55   56   57   58